Danaher Announces Human Resources And Accounting Leadership Transition Plans

 
 

- Danaher Corporation (NYSE: DHR) (the "Company") today announced that, effective April 1, 2022, Georgeann F. Couchara will succeed Angela S. Lalor as Senior Vice President, Human Resources. At that time, Ms. Lalor will move to a part time, advisory role until her retirement in the first quarter of 2023. Ms. Couchara, currently Vice President, Talent for the Company, will join the Danaher Leadership Team and the Office of the Chief Executive, reporting to Rainer M. Blair Danaher's President & Chief Executive Officer.

 

Additionally, the Company announced that Christopher M. Bouda will succeed Robert S. Lutz as Chief Accounting Officer of Danaher, effective January 1, 2022 , reporting to Matthew R. McGrew , Danaher's Executive Vice President & Chief Financial Officer. Mr. Bouda is currently Vice President, Finance for Danaher. Mr. Lutz will continue to work with the Company on a part-time basis until his retirement in the fourth quarter of 2022.

 

Mr. Blair stated: "I have had the distinct pleasure of working with Georgeann for nearly a decade. Her years of experience and success at Danaher, leading HR teams at the operating company, platform and corporate levels, uniquely position her to take on this important role. I am confident that Georgeann will help shepherd Danaher into our next chapter while ensuring we meet our evolving global talent needs."

 

Blair continued: "It has been a privilege to work alongside Angie. Under her leadership, we have materially enhanced our capabilities in acquiring, developing and engaging the diverse talent needed to support Danaher's ambitious business strategies and objectives. Her passion for leadership development will have longstanding impact across the Company. We are pleased that Angie will continue to work with us for some time to ensure a seamless transition and provide the strategic counsel we value so highly."

 

Mr. McGrew added: "Bob is a valued business partner to me and Danaher's entire leadership team. He has had a remarkable impact on our finance organization, advancing our capabilities and serving as a trusted mentor and coach to many. Bob has been involved in every significant Danaher transaction for the last twenty years, including acquisitions, debt and equity offerings, and the creation of two independent public companies. The totality of Bob's contributions has created tremendous value for associates and shareholders alike. I am confident that Chris will bring this same level of excellence to the role."

 

Ms. Lalor joined Danaher in 2012. Among her many accomplishments, Ms. Lalor led the organizational and talent strategy in support of Danaher's portfolio evolution. Ms. Lalor is a National Academy of Human Resources Fellow.

 

Ms. Couchara joined Danaher in 2004. In her current role, Ms. Couchara is responsible for talent attraction, acquisition, leadership development, succession planning, associate engagement, and change management. Previously, she led Human Resources for the Life Sciences companies of Danaher and, prior to that, at multiple Danaher operating companies. Ms. Couchara earned a Bachelor of Arts degree in Applied Psychology and a Master of Arts in Industrial and Labor Relations from Indiana University of Pennsylvania , as well as a Master of Business Administration degree from Georgetown University .

 

Mr. Lutz joined Danaher in 2002 and served in a series of progressively more responsible finance positions before his appointment to Senior Vice President and Chief Accounting Officer in 2010.

 

Mr. Bouda joined Danaher in 2016 as Vice President, Finance.  Prior to Danaher, Mr. Bouda spent 12 years with General Electric in roles of increasing responsibility. Prior to General Electric, Mr. Bouda was employed with Deloitte & Touche and Arthur Andersen. Mr. Bouda holds a bachelor's degree in Accounting from University of Wisconsin-Madison and is a Certified Public Accountant.

 

  ABOUT DANAHER  

 

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 69,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential . For more information, please visit www.danaher.com .

 

  FORWARD-LOOKING STATEMENTS  

 

Statements in this release that are not strictly historical, including any statements regarding events or developments that we believe or anticipate will or may occur in the future are "forward-looking" statements within the meaning of the federal securities laws. There are a number of important factors that could cause actual results, developments and business decisions to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. These factors include, among other things, those set forth in our SEC filings, including our 2020 Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the second quarter of 2021. These forward-looking statements speak only as of the date of this release and except to the extent required by applicable law, the Company does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.

 

 Cision View original content: https://www.prnewswire.com/news-releases/danaher-announces-human-resources-and-accounting-leadership-transition-plans-301360888.html  

 

SOURCE Danaher Corporation

 
 

News Provided by PR Newswire via QuoteMedia

The Conversation (0)
illustration of brain and cell phone.

BlinkLab Completes First Patient Test for US Autism Diagnostic Study

Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians.

BlinkLab states in its Wednesday (March 12) release that the study is the largest digital diagnostic trial for autism in the US, with its aim being to support the early detection of developmental conditions like autism.

The first patient test took place at PriMED Clinical Research in Dayton, Ohio. PriMED, a division of PriMED Physicians, is one of two clinical sites selected for the study’s initial phase, which is targeting 100 patients.

Keep reading...Show less
HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Limited (ASX: HMD), a medical data and technology company leading the digital transformation of maternity care, is delighted to announce it has entered into a collaboration agreement with Garmin (NYSE: GRMN), a leading global provider of smartwatches and GPS-enabled products, aimed at enhancing remote pregnancy monitoring and expanding the range of health data available to expectant mothers and their healthcare providers.

Keep reading...Show less
Cardiologist wearing virtual reality glasses.

2 Biggest Medical Device ETFs in 2025

Exchange-traded funds (ETFs) are a popular investment strategy, and generally contain a variety of publicly traded companies under one stock symbol, often with a focus on a specific sector.

Depending on the ETF, investors may be able to track up-and-coming companies, get exposure to top firms or a mix of both. Aside from stocks, some ETFs also track commodities or bonds.

In the healthcare industry, medical device ETFs bring together companies that go to great lengths to develop pharmaceutical-based technology that can improve the lives of patients.

Keep reading...Show less
Cyclomedica

Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

Cyclopharm Limited (ASX: CYC) is pleased to announce the signing of a major contract with Hospital Corporation of America Healthcare (HCA), one of the largest single healthcare providers in the United States. This agreement marks a significant milestone for the company which will allow the deployment of Technegas® in up to 169 nuclear medicine departments across HCA’s extensive network.1

Keep reading...Show less
CONNEQT App Launches in USA as Pulse Deliveries Commence

CONNEQT App Launches in USA as Pulse Deliveries Commence

Cardiex Limited (CDX:AU) has announced CONNEQT App Launches in USA as Pulse Deliveries Commence

Download the PDF here.

Female doctor with clipboard talking to smiling female patient at hospital.

Revolutionizing Women's Health: Antifungal Innovation Brings New Investment Opportunities

The intersection of women's health and antifungal innovation represents a pivotal moment in healthcare, offering both transformative medical advancements and compelling investment opportunities.

The groundbreaking developments in antifungal treatments specifically targeting women's health issues present a substantial market potential, resulting in rising investor interest in this rapidly evolving sector.

Despite comprising half the global population, women face unique health challenges that have historically received insufficient attention and investment. Among these health challenges, vaginal candidiasis stands out as a persistent and widespread issue affecting millions of women worldwide.

Keep reading...Show less

Latest Press Releases

Related News

×